Centers for Medicare and Medicaid Services and American Dental Association Establish New Reimbursement for EXPAREL

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. APGE
6. MU
7. USO
8. HOOD
9. DFTX
10. RGNX

Go back to Centers for Medicare and Medicaid Services and American Dental Association Establish New Reimbursement for EXPAREL

Pacira Pharmaceuticals (PCRX) PT Raised to $46 at Mizuho Securities Following 3Q

November 5, 2018 7:16 AM EST

Mizuho Securities analyst Irina Koffler raised the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $46.00 (from $43.00) while maintaining a Neutral rating following the company's 3Q earnings report. Mizuho Securities raised 2018 Exparel sales to $331.8M (from $321.2M) and 2019 estimates to $396.5M (from $376.8M prior); both above... More